Samuel Agresta
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Genetics top 10%
Papers in
-
- Acute Myeloid Leukemia Research 8
- Oncology 8
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Hatem Soliman (1 shared paper)Courtney D. DiNardo (9 shared papers)Martin S. Tallman (6 shared papers)Stéphane de Botton (7 shared papers)Eytan M. Stein (8 shared papers)Daniel A. Pollyea (5 shared papers)Eyal C. Attar (4 shared papers)Gina Z. D’Amato (2 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (6 papers)Cancer Control (3 papers)Clinical Cancer Research (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Samuel Agresta
25 papers receiving 949 citations
Peers
Comparison fields: 5 of 71
- Hematology 290
- Genetics 108
- Cancer Research 134
- Oncology 227
- Pulmonary and Respiratory Medicine 171
Countries citing papers authored by Samuel Agresta
This map shows the geographic impact of Samuel Agresta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Agresta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Agresta more than expected).
Fields of papers citing papers by Samuel Agresta
This network shows the impact of papers produced by Samuel Agresta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Agresta. The network helps show where Samuel Agresta may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Agresta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 168 | |
| 2 | 2013 | 147 | |
| 3 | 2012 | 93 | |
| 4 | 2010 | 91 | |
| 5 | 2008 | 88 | |
| 6 | 2017 | 74 | |
| 7 | 2011 | 57 | |
| 8 | 2008 | 38 | |
| 9 | 2014 | 25 | |
| 10 | 2008 | 25 | |
| 11 | 2019 | 24 | |
| 12 | 2013 | 23 | |
| 13 | 2020 | 22 | |
| 14 | 2007 | 20 | |
| 15 | 2017 | 13 | |
| 16 | 2013 | 13 | |
| 17 | 2023 | 12 | |
| 18 | 2017 | 11 | |
| 19 | 2012 | 6 | |
| 20 | 2018 | 6 |
About Samuel Agresta
Samuel Agresta is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 968 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Sarcoma Diagnosis and Treatment (4 papers), Protein Degradation and Inhibitors (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Genomics and Diagnostics (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (290 citations), Genetics (108 citations), Cancer Research (134 citations), Oncology (227 citations) and Pulmonary and Respiratory Medicine (171 citations). Samuel Agresta has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Hatem Soliman, Courtney D. DiNardo, Martin S. Tallman, Stéphane de Botton, Eytan M. Stein, Daniel A. Pollyea, Eyal C. Attar, Gina Z. D’Amato, Anthony S. Stein and Hagop M. Kantarjian. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Control, Clinical Cancer Research and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.